Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadashi Watabe

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2022
[Investigator-Initiated Clinical Trial of 211At-NaAt against Refractory Thyroid Cancer]Tadashi Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 1, 2026
[Clinical Application of Targeted Alpha Therapy Using Astatine]Tadashi Watabe
Hellenic Journal of Nuclear Medicine|December 15, 2015
(18)F-FBPA as a tumor specific tracer of L-type amino acid transporter 1 (LAT1): PET evaluation in tumor and inflammation compared to (18)F-FDG and (11)C-methionineTadashi Watabe, Jun Hatazawa
Frontiers in Neuroscience|August 13, 2019
Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-ReviewTadashi Watabe, Jun Hatazawa
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor PET/CT in Gastric CancerTadashi Watabe, Frederik L Giesel
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 22, 2002
[Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]Tadashi Watabe, Kenichiro Ogura, Takahito Nishiyama
Annals of Nuclear Medicine|November 8, 2022
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranosticsBarbara Hertz, Tadashi Watabe, Richard P Baum
Journal of Natural Products|February 1, 2005
Potent CYP3A4 inhibitory constituents of Piper cubebaTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Biological & Pharmaceutical Bulletin|March 4, 2005
Mechanism-based inhibition of CYP3A4 by constituents of Zingiber aromaticumTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Life Sciences|March 8, 2005
Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibitionTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2022
[Investigator-Initiated Clinical Trial of 211At-NaAt against Refractory Thyroid Cancer]Tadashi Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 1, 2026
[Clinical Application of Targeted Alpha Therapy Using Astatine]Tadashi Watabe
Hellenic Journal of Nuclear Medicine|December 15, 2015
(18)F-FBPA as a tumor specific tracer of L-type amino acid transporter 1 (LAT1): PET evaluation in tumor and inflammation compared to (18)F-FDG and (11)C-methionineTadashi Watabe, Jun Hatazawa
Frontiers in Neuroscience|August 13, 2019
Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-ReviewTadashi Watabe, Jun Hatazawa
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor PET/CT in Gastric CancerTadashi Watabe, Frederik L Giesel
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 22, 2002
[Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]Tadashi Watabe, Kenichiro Ogura, Takahito Nishiyama
Annals of Nuclear Medicine|November 8, 2022
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranosticsBarbara Hertz, Tadashi Watabe, Richard P Baum
Journal of Natural Products|February 1, 2005
Potent CYP3A4 inhibitory constituents of Piper cubebaTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Biological & Pharmaceutical Bulletin|March 4, 2005
Mechanism-based inhibition of CYP3A4 by constituents of Zingiber aromaticumTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Life Sciences|March 8, 2005
Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibitionTepy Usia, Tadashi Watabe, Shigetoshi Kadota, et al.
Pageof 19